Intrexon Corp. (NYSE:XON) rose 3.6% during mid-day trading on Wednesday . The company traded as high as $28.34 and last traded at $27.92, with a volume of 1,122,996 shares traded. The stock had previously closed at $26.96.

XON has been the subject of a number of recent research reports. Vetr upgraded shares of Intrexon Corp. from a “hold” rating to a “strong-buy” rating and set a $33.69 price objective for the company in a report on Wednesday, August 3rd. Zacks Investment Research upgraded shares of Intrexon Corp. from a “hold” rating to a “buy” rating and set a $29.00 price objective for the company in a report on Tuesday, July 19th. Stifel Nicolaus reiterated a “buy” rating on shares of Intrexon Corp. in a report on Thursday, April 21st. Wunderlich reiterated a “buy” rating and issued a $50.00 price objective on shares of Intrexon Corp. in a report on Thursday, July 7th. Finally, Griffin Securities reiterated a “buy” rating and issued a $65.00 price objective on shares of Intrexon Corp. in a report on Tuesday, June 7th. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Intrexon Corp. has a consensus rating of “Buy” and a consensus price target of $42.96.

The firm’s 50 day moving average is $25.67 and its 200-day moving average is $29.71. The company’s market capitalization is $3.31 billion.

Intrexon Corp. (NYSE:XON) last issued its quarterly earnings data on Tuesday, August 9th. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by $0.16. The company had revenue of $52.50 million for the quarter, compared to analyst estimates of $53.78 million. The firm’s revenue for the quarter was up 17.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.37) EPS. On average, equities analysts forecast that Intrexon Corp. will post ($1.35) EPS for the current year.

Other large investors recently modified their holdings of the company. State of Wisconsin Investment Board raised its stake in shares of Intrexon Corp. by 2.5% in the fourth quarter. State of Wisconsin Investment Board now owns 35,410 shares of the company’s stock worth $1,068,000 after buying an additional 880 shares during the last quarter. Bank of Montreal Can raised its stake in shares of Intrexon Corp. by 16.8% in the fourth quarter. Bank of Montreal Can now owns 40,010 shares of the company’s stock worth $1,207,000 after buying an additional 5,742 shares during the last quarter. Rhumbline Advisers raised its stake in shares of Intrexon Corp. by 6.7% in the fourth quarter. Rhumbline Advisers now owns 46,016 shares of the company’s stock worth $1,387,000 after buying an additional 2,890 shares during the last quarter. Swiss National Bank raised its stake in shares of Intrexon Corp. by 3.8% in the fourth quarter. Swiss National Bank now owns 62,500 shares of the company’s stock worth $1,884,000 after buying an additional 2,300 shares during the last quarter. Finally, Trexquant Investment LP bought a new stake in shares of Intrexon Corp. during the fourth quarter worth approximately $2,590,000.

Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.